Abstract
Whether unilateral or bilateral drainage should be performed for malignant hilar biliary obstruction remains a matter of debate. Although a Y-stent with a central wide-open mesh facilitates bilateral stent placement, it has its own limitations. This study aims to evaluate the feasibility and efficacy of a newly designed Y-configured bilateral self-expanding metallic stent (SEMS) for the treatment of hilar biliary obstruction. In this retrospective study, 14 consecutive patients with unresectable malignant hilar biliary obstruction (Bismuth type II or higher), who underwent placement of a newly designed Y-configured bilateral SEMS for hilar biliary obstruction from April 2013 to March 2015, were included into this study. Data on technical success, clinical success, stent patency, complications and patient survival were collected. Technical and clinical success was 100 and 92.9%, respectively. Mean serum bilirubin level was significantly decreased 1month after stent placement (P<0.01). Furthermore, two patients (14.3%) had early complications (one patient had severe hemobilia and one patient had cholangitis), and two patients (14.3%) had late complications (one patient had cholangitis and one patient had cholecystitis). During the mean follow-up period of 298days (range 89-465days), six patients (42.9%) developed stent occlusion caused by tumor ingrowth or overgrowth (n=5) and sludge (n=1). Median stent patency and overall survival times were 281days (95% CI 175.9-386.1days) and 381days (95% CI 291.4-470.6days), respectively. The use of the newly designed Y-configured bilateral SEMS is feasible and effective for hilar biliary obstruction using port docking deployment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.